Propionibacterium acnes infections in patients with idiopathic scoliosis: a case-control study and review of the literature. by Swarup, I et al.
UCSF
UC San Francisco Previously Published Works
Title
Propionibacterium acnes infections in patients with idiopathic scoliosis: a case-control 
study and review of the literature.
Permalink
https://escholarship.org/uc/item/9496h4zb
Journal
Journal of children's orthopaedics, 12(2)
ISSN
1863-2521
Authors
Swarup, I
Gruskay, J
Price, M
et al.
Publication Date
2018-04-01
DOI
10.1302/1863-2548.12.170212
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Original Clinical Article
Propionibacterium acnes infections in patients with 
idiopathic scoliosis: a case-control study and review 
of the literature
I. Swarup1
J. Gruskay1
M. Price1
J. Yang2
J. Blanco1
S. Perlman3
R. Widmann1
Abstract
Purpose Surgical site infection (SSI) caused by Propionibac-
terium acnes is an infrequent but devastating complication 
after spinal fusion. The purpose of this study was to identify 
risk factors for SSI with Propionibacterium acnes after spinal 
fusion for juvenile and adolescent idiopathic scoliosis (JIS and 
AIS).
Methods A case-control study was performed. Each case was 
matched 2:1 for age, gender and diagnosis. Retrospective 
chart review was performed to obtain relevant demographic, 
surgical and clinical data for all cases and controls. Statistical 
analysis included paired t-test and McNemar test, as well as 
exact logistic regression and robust regression models. 
Results This study included ten infection cases (eight AIS, two 
JIS) and 20 controls (16 AIS, four JIS). In total, six infected 
cases presented within two weeks of the index procedure 
(acute infection) and four infected cases presented more than 
one year from the index procedure (delayed infection). The 
most common presentation for acute infections was wound 
drainage, while back pain was more common in delayed in-
fections. All infections were successfully treated with surgical 
irrigation and debridement and postoperative antibiotics. 
Hardware was removed for patients with delayed infections. 
The strongest risk factor for infection was increased require-
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ment for blood transfusion, but it did not reach statistical sig-
nificance. 
Conclusion SSI with Propionibacterium acnes is an important 
complication after spinal fusion for idiopathic scoliosis. These 
infections can be successfully treated, but larger studies are 
needed to further identify risk factors and establish standard-
ized guidelines for the treatment and prevention of this com-
plication. 
Level of Evidence Level III
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Introduction
Spinal fusion is a common treatment for correcting and 
preventing the progression of spinal deformity for juvenile 
idiopathic scoliosis (JIS) and adolescent idiopathic scoliosis 
(AIS). However, this procedure is associated with various 
postoperative complications, and adverse events follow-
ing surgery may occur in 3% to 23% of cases.1-6 Surgical 
site infection (SSI) is an infrequent but devastating compli-
cation, and it is the most common reason for readmission 
following spinal fusion surgery for idiopathic scoliosis.1,7
Several studies have reported the incidence of SSI fol-
lowing surgery for idiopathic scoliosis. Incidence has been 
reported to range from 0.2% to 9%, but can vary based on 
patient population, study parameters and definition for 
SSI (deep versus superficial, acute versus delayed).3,4,6,8,9 A 
recent study using a large, national, multi-centre database 
reported a 1.6% incidence of infection (0.6% deep, 1.0% 
superficial) within 30 days of surgery.1 While the incidence 
of acute infection is low, delayed infection is an import-
ant but under-recognized complication in the AIS pop-
ulation. Two studies reported a 4.7% to 6.7% incidence 
of late infection (more than six months after index pro-
cedure),8,9 and interestingly, low virulence skin-flora such 
as Propionibacterium acnes and Staphylococcus epidermidis 
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were cultured in many of these cases. Other investigations 
reported similar findings.10-13 In a recent study from our 
institution, we reported a deep infection rate of 1% for AIS 
patients over a 12 year period.14 Furthermore, the most 
common pathogen implicated in infections in patients 
with idiopathic scoliosis was Propionibacterium acnes.14 
Even though Propionibacterium acnes is traditionally asso-
ciated with delayed infections, it is now recognized as an 
important cause for acute infections as well.14 
Many studies have focused on risk factors and preven-
tion of SSI following surgery for idiopathic scoliosis. More 
specifically, factors such as American Society of Anesthesi-
ologist (ASA) grade,15 obesity,1,15 use of allograft,16 length 
of surgery,1 number of levels fused,1 blood transfusion,11 
surgeon factors,16 prior medical history16 and use of post-
operative drain16 have been associated with SSIs. However, 
there is a paucity of literature focusing on risk factors and 
best practice guidelines for preventing infections with low 
virulent organisms, particularly Propionibacterium acnes. 
The purpose of this study is to assess for independent risk 
factors for the development of SSI with Propionibacterium 
acnes and to describe the current literature and treatment 
recommendations for the prevention of these infections. 
Patients and methods
We performed a case-control study to identify risk factors 
associated with the development of Propionibacterium 
acnes infections in patients with idiopathic scoliosis. First, 
we identified all patients that underwent spinal fusion for 
idiopathic scoliosis at our institution between 2000 and 
2012 and subsequently developed a SSI. We previously 
published the details of this cohort, including the overall 
incidence of SSIs and proportion of SSIs with Propionibac-
terium acnes in idiopathic scoliosis.14 We queried our paedi-
atric medicine division and paediatric spine surgeons, and 
identified additional patients with idiopathic scoliosis that 
presented with a SSI between 2012 and 2015. Inclusion 
criteria included age < 21 years at time of index procedure, 
spinal fusion for JIS or AIS at our institution and treatment 
for a postoperative SSI at our institution. To ensure a 
minimum follow-up period of at least one year, patients 
presenting with a SSI through 2015 were included. All 
patients underwent posterior spinal fusion, and implant 
density was determined by patient factors, spinal defor-
mity and surgeon preference. Patients presenting from 
an outside facility following index procedure for manage-
ment of postoperative infection were excluded. This study 
was approved by our institutional review board.
Chart review
We reviewed the charts of all patients that developed a 
postoperative SSI with Propionibacterium acnes to collect 
demographic, surgical, infection and microbiology data. 
A 2:1 control cohort matched by age, gender and diag-
nosis was also obtained from the initial group of patients 
described above. These control patients did not develop 
a SSI after surgery, and chart review was performed to 
collect demographic and surgical data for these patients 
as well. We compared the following variables between 
the cases and controls: body mass index (BMI), surgeon, 
number of levels fused, ASA grade, length of surgery, 
use of perioperative antibiotics, surgical site preparation, 
estimated blood loss, transfusion requirement, use of 
vancomycin powder, type of lavage (with or without anti-
biotics), implant material, use of cross-links, use of post-
operative drain, length of drain use and length of stay. All 
of these variables were determined after a literature review 
of risk factors for SSI after spinal fusion.1,11,15-18 We further 
reviewed the literature to identify and summarize studies 
focusing on the diagnosis, prevention and management 
of Propionibacterium acnes infections in orthopaedic sur-
gery.
Statistical analysis
Descriptive statistics were summarized using means and 
sds for continuous variables, and frequencies and percent-
ages for categorical variables. The cases and controls were 
matched for age, gender and diagnosis. Paired t-test and 
McNemar test were performed to compared continuous 
and categorical variables between both groups, respec-
tively. Exact logistic regression and robust regression mod-
els were used to examine if there are associations between 
variables and risk of infection. Statistical significance was 
set to 0.05, and all analyses were performed using Stata 
14.0 (StataCorp, College Station, Texas). 
Results
Our study included ten patients with SSI after spinal 
fusion surgery (Table 1). More specifically, six cases of 
infection were identified from the previous study,14 and 
between 2012 and 2015, four additional cases of infection 
with Propionibacterium acnes were managed at our insti-
tution. There were no other cases of infection after spinal 
deformity surgery in patients with JIS or AIS between 2012 
and 2015. In our cohort, nine patients had culture-positive 
infections with Propionibacterium acnes and one patient 
had a culture-negative infection that was treated as a 
presumed Propionibacterium acnes infection. In addition, 
eight patients had a diagnosis of AIS and two patients had 
a diagnosis of JIS. The mean age at time of surgery was 
15 years (range 13 to 18 years) and there were an equal 
number of male and female patients. Our control group 
was comprised of 20 patients (16 AIS, four JIS) matched 
for age, gender and diagnosis.
P. ACNES INFECTIONS IN PATIENTS WITH SCOLIOSIS
J Child Orthop 2018;12:173-180 175
Ta
b
le
 1
 C
as
es
 o
f 
su
rg
ic
al
 s
it
e 
in
fe
ct
io
n
 a
ft
er
 s
p
in
al
 f
us
io
n
 s
ur
g
er
y
Pa
ti
en
t 
N
um
b
er
G
en
d
er
A
g
e 
at
 o
p
er
at
io
n
 
(y
rs
)
D
ia
g
n
o
si
s
B
o
d
y 
m
as
s 
in
d
ex
Su
rg
eo
n
 (
co
d
ed
)
N
um
b
er
 
o
f 
le
ve
ls
 
fu
se
d
A
SA
 g
ra
d
e
Le
n
g
th
 o
f 
Su
rg
er
y 
(h
rs
 +
m
in
s)
U
se
 o
f 
p
er
io
p
er
at
iv
e 
ab
x 
(t
yp
e)
Su
rg
ic
al
 s
it
e 
p
re
p
ar
at
io
n
*
Es
ti
m
at
ed
 
b
lo
o
d
 lo
ss
 (
cc
)
Tr
an
sf
us
io
n
 
vo
lu
m
e 
 
(1
 u
n
it
 =
 2
50
 c
c)
1
M
17
A
IS
20
.4
A
11
1
4 
+ 
20
A
nc
ef
3
18
00
3
2
F
18
A
IS
21
.3
D
8
1
3 
+ 
32
A
nc
ef
1
80
0
2
3
F
14
A
IS
18
.5
A
5
1
2 
+ 
25
A
nc
ef
3
40
0
0
4
F
14
A
IS
19
.7
B
11
3
4 
+ 
56
A
nc
ef
1
80
0
1
5
M
16
A
IS
23
.3
B
12
2
3 
+ 
11
A
nc
ef
1
34
00
0
6
F
15
JIS
24
.5
D
13
2
3 
+ 
20
A
nc
ef
1
18
00
0
7
M
16
A
IS
 
19
.8
D
14
2
7 
+ 
15
A
nc
ef
2
20
00
1
8
F
13
A
IS
 
16
.7
D
12
1
4 
+ 
47
A
nc
ef
1
10
00
2
9
M
14
JIS
18
.4
C
13
2
6 
+ 
37
A
nc
ef
3
15
00
0
10
M
15
A
IS
18
.7
F
11
2
3
A
nc
ef
2
60
0
0
Pa
ti
en
t 
N
um
b
er
In
tr
ao
p
er
at
iv
e 
us
e 
o
f 
va
n
co
m
yc
in
 
p
o
w
d
er
U
se
 o
f 
la
va
g
e 
w
it
h
 a
b
x 
Im
p
la
n
t 
m
at
er
ia
l**
C
ro
ss
-l
in
k 
us
e
U
se
 o
f 
p
o
st
o
p
er
at
iv
e 
d
ra
in
Ti
m
e 
o
f 
d
ra
in
 
re
m
o
va
l
D
ur
at
io
n
 
o
f 
h
o
sp
it
al
 
st
ay
Pa
th
o
g
en
Po
st
o
p
er
at
iv
e 
d
ay
 o
f 
in
fe
ct
io
n
R
em
o
va
l o
f 
h
ar
d
w
ar
e
Le
n
g
th
 o
f 
 
p
o
st
o
p
er
at
iv
e 
ab
x
1
N
Y
1
N
N
N
/A
10
P.
 a
cn
es
 
6
N
6 
w
ks
2
N
Y
2
N
Y
PO
D
 2
4
P.
 a
cn
es
7
N
6 
w
ks
3
N
Y
3
N
Y
PO
D
 2
6
P.
 a
cn
es
12
N
10
 d
ay
s
4
N
Y
2
N
Y
PO
D
 2
8
-
13
N
6 
w
ks
5
N
Y
1
Y
Y
PO
D
 2
6
P.
 a
cn
es
14
24
Y
6 
w
ks
6
N
Y
2
N
Y
PO
D
 2
6
P.
 a
cn
es
 
12
29
N
1 
yr
7
Y
Y
3
Y
Y
PO
D
 4
5
P.
 a
cn
es
38
2
Y
9 
w
ks
8
N
Y
2
N
Y
PO
D
 4
6
P.
 a
nc
es
20
93
Y
6 
w
ks
9
Y
Y
3
N
Y
PO
D
 1
9
P.
 a
cn
es
2
N
4 
w
ks
10
Y
Y
3
N
Y
PO
D
 3
4
P.
 a
cn
es
14
N
6 
w
ks
*1
 =
 B
et
ad
in
e 
on
ly
, 2
 =
 c
hl
or
he
xi
di
ne
 g
lu
co
na
te
 o
nl
y,
 3
 =
 B
et
ad
in
e 
+ 
ch
lo
rh
ex
id
in
e 
gl
uc
on
at
e
**
1 
= 
tit
an
iu
m
, 2
 =
 s
ta
in
le
ss
 s
te
el
, 3
 =
 c
ob
al
t c
hr
om
e
N
/A
, n
ot
 a
p
p
lic
ab
le
; A
SA
, A
m
er
ic
an
 S
oc
ie
ty
 o
f A
ne
st
he
si
ol
og
is
ts
; A
bx
, a
nt
ib
io
tic
s;
 A
IS
, a
do
le
sc
en
t i
di
op
at
hi
c 
sc
ol
io
si
s;
 JI
S,
 ju
ve
ni
le
 id
io
p
at
hi
c 
sc
ol
io
si
s;
 P
O
D
, p
os
to
p
er
at
iv
e 
da
y
P. ACNES INFECTIONS IN PATIENTS WITH SCOLIOSIS
176 J Child Orthop 2018;12:173-180
Infection data
Patients with SSI had surgery between 2006 and 2015. 
Infections were noted in six patients within two weeks of 
the index procedure (acute infection), and four patients 
developed infections over one year from the index pro-
cedure (delayed infection). No patients had notable back 
acne or dermatological complaints at the time of their 
surgical consultation or preoperative visit. The present-
ing complaint was wound drainage for all acute infec-
tions. On the other hand, delayed infections typically 
presented with complaints of back pain. The most com-
mon laboratory abnormalities included leukocytosis in 
two out of four patients (12 700 and 14 810 white blood 
cells per mcL) and elevated inflammatory markers in two 
out of four patients (c-reactive protein (CRP)) 3.6 mg/
dl and 6.7 mg/dl, normal < 1 mg/dl). The work-up for 
delayed infections was comprised of laboratory tests, 
advanced imaging, and in one case, bone culture and 
aspiration.
Regardless of acute or delayed presentation, all 
patients were treated with operative management and 
postoperative antibiotics. Acute infections were treated 
with irrigation and debridement, and two patients with 
acute infections had this procedure during their index 
admission. Delayed infections were treated with irrigation 
and debridement as well as removal of hardware in three 
out of four cases. A robust fusion mass was confirmed on 
CT scans and intraoperatively in all patients that under-
went hardware removal. Intraoperative findings were sig-
nificant for a hypertrophic soft-tissue reaction around the 
implant in one patient with a delayed infection; a deep 
sinus tract with frank purulence in another patient with 
delayed infection; superficial purulence in one patient 
with an acute infection; and seroma formation in two 
other patients with acute infections.
Postoperative antibiotic treatment for acute infections 
included cephalexin, ampicillin-sulbactam or ciproflox-
acin and clindamycin, and duration of treatment was 
most commonly six weeks, but ranged from ten days to 
six weeks. Antibiotic treatment for delayed infections was 
a short course of intravenous antibiotics followed by oral 
antibiotics (cephalexin or amoxicillin), and the duration of 
treatment ranged from six weeks to one year. Treatment 
was successful in all patients in this study.
Variables
Univariate logistic regression analysis was performed to 
determine any significant risk factors for infection (Table 2). 
There were no significant differences in BMI, surgeon and 
number of levels fused between cases and controls (p > 
0.05). Similarly, the length of surgery, surgical site prepa-
ration and estimated blood loss did not significantly differ 
between groups (p > 0.05). However, 3/10 infection cases 
Table 2 Risk factors for surgical site infection after spinal fusion surgery
Control (n = 20) Case (n = 10) p-value
Gender 0.796
    Male 9 (45%) 5 (50%)
    Female 11 (55%) 5 (50%)
Age, mean (sd) 15.2 (1.48) 15.2 (1.55) 0.932
Body Mass Index 0.540
    Underweight/normal 18 (90%) 10 (100%)
    Overweight/obese 2 (10%) 0
Surgeon 0.914
    A 3 (15%) 2 (20%)
    B 5 (25%) 2 (20%)
    C 3 (15%) 1 (10%)
    D 7 (35%) 4 (40%)
    E 0 1 (10%)
    F 1 (5%) 0
    G 1 (5%) 0
Number of levels fused 0.314
    4 1 (5%) 0
    5 0 1 (10%)
    8 0 1 (10%)
    10 4 (20%) 0
    11 4 (20%) 3 (30%)
    12 6 (30%) 2 (20%)
    13 4 (20%) 2 (20%)
    14 0 1 (10%)
    15 1 (5%) 0
ASA grade 0.513
    1 9 (45%) 4 (40%)
    2 11 (55%) 5 (50%)
    3 0 1 (10%)
Length of surgery (mins), mean (sd) 288.3 (65) 284.3 (90.5) 0.900
Perioperative antibiotics N/A
    No 0 0
    Yes 20 (100%) 10 (100%)
Surgical site preparation 0.651
    Betadine only 13 (65%) 5 (50%)
    Chloraprep only 3 (15%) 2 (20%)
    Chlroaprep+betadine 4 (20%) 3 (30%)
Blood loss (cc), mean (sd) 1327.5 (791.1) 1410 (895) 0.805
Intraoperative blood transfusion (units) 0.343
    0 16 (80%) 6 (60%)
    1 4 (20%) 3 (30%)
    3 0 1 (10%)
Postoperative blood transfusion (units) 0.670
    0 14 (70%) 8 (80%)
    1 5 (25%) 1 (10%)
    2 1 (5%) 1 (10%)
Total blood transfusion (units) 0.152
    0 10 (50%) 5 (50%)
    1 9 (45%) 2 (20%)
    2 1 (5%) 2 (20%)
    3 0 1 (10%)
Vancomycin powder 0.372
    No 17 (85%) 7 (70%)
    Yes 3 (15%) 3 (30%)
Lavage type 0.615
    No antibiotics 1 (5%) 0
    Yes (bacitracin, polymyxin) 17 (85%) 9 (90%)
    Yes (polymyxin) 2 (10%) 0
    Yes (bacitracin) 0 1 (10%)
Implant material 0.880
    Cobalt chrome 6 (30%) 4 (40%)
    Stainless steel 10 (50%) 4 (40%)
    Titanium 4 (20%) 2 (20%)
Use of cross-link 0.234
    No 10 (50%) 8 (80%)
    Yes 10 (50%) 2 (20%)
Drain use 0.333
    No 0 1 (10%)
    Yes 20 (100%) 9 (90%)
Drain removal 0.256
    N/A 0 1 (10%)
    POD 1 1 (5%) 1 (10%)
    POD 2 12 (60%) 5 (50%)
    POD 3 6 (30%) 1 (10%)
    POD 4 1 (5%) 2 (20%)
Length of stay (days), mean (sd) 5.25 (1.3) 563 (1.3) 0.266
ASA, American Society of Anesthesiologists; POD, postoperative day
Paired t-test was used to compare continuous variables and McNemar test 
was used to compare categorical variables. 
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and 1/20 controls required two or more units of blood in 
the perioperative period (p = 0.15).
Furthermore, all patients received cefazolin for periop-
erative antibiotic prophylaxis, and there were no signifi-
cant differences in vancomycin powder use and antibiotic 
lavage between groups (p > 0.05). There was also no sig-
nificant difference in implant material and the use of cross-
links between groups (p > 0.05). Drains were placed in 
almost all cases, and these drains were typically removed 
on postoperative day (POD) 2 for cases and controls (p > 
0.05). After excluding infection cases that underwent irri-
gation and debridement during the index admission, the 
mean length of stay did not differ between groups (p > 
0.05).
All variables were dichotomized based on their distri-
bution, and odds ratios (OR) were calculated (Fig. 1). ASA 
grade (Grades 2 and 3) (OR 1.22, 95% confidence interval 
(CI) 0.21 to 7.85), surgical site preparation (both betadine 
and chlorhexidine gluconate) (OR 1.68, 95% CI 0.19 to 
13.2), use of vancomycin powder (OR 2.35, 95% CI 0.25 
to 22.31), intraoperative blood transfusion (OR 2.57, 95% 
CI 0.36 to 19.25) and length of stay (greater than five 
days) (OR 2.66, 95% CI 0.36 to 23.88) had the largest ORs 
for infection. We re-analyzed the data after excluding the 
patient with a culture-negative infection and found no 
other significant associations.
Discussion
SSI is an infrequent but devastating complication of spinal 
fusion surgery for idiopathic scoliosis. Propionibacterium 
acnes is a well described cause of infection in these patients, 
however, there is limited data on its presentation, risk fac-
tors and management. In this study, the most common 
presentation for acute infections with Propionibacterium 
acnes was wound drainage, while back pain was more 
common in delayed infections. All infections were suc-
cessfully treated with surgical irrigation and debridement 
followed by antibiotics. We did not find any significant risk 
factor for the development of infection with Propionibac-
terium acnes with our sample size. However, factors such 
as transfusion requirement, surgical site preparation, use 
of vancomycin powder and length of stay may be impli-
cated, and require additional study.
Fig. 1 Odd ratios and associated 95% confidence interval for risk factors of infection with Propionibacterium acnes (BMI, body mass 
index; ASA, American Society of Anesthesiologists; POD, postoperative day).
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Propionibacterium acnes is a gram-positive, facultative 
anaerobe with a slow growth rate and low virulence.19-21 It 
is part of the skin flora populating the oily pilosebaceous 
glands of the chest, back, manubrium and ear,22-24 and it is 
considered an important pathogen in infections following 
various orthopaedic procedures, particularly in spine and 
shoulder surgery.8,20,22,25 Due to its deep dermal location, 
Propionibacterium acnes is relatively sheltered from the 
standard perioperative antibiotic regimen26 and surgical 
skin preparations.27 Furthermore, it forms a polysaccha-
ride matrix biofilm in the presence of implanted materials, 
making its eradication difficult without surgical interven-
tion.28,29 Inoculation into the deep wound is believed to 
occur with skin incision,25,27,30,31 however, other routes 
such as hematogenous spread, introduction by prior pro-
cedure or surgical instrument and provider contamination 
have also been proposed.25
Data regarding prevention strategies for Propioni-
bacterium acnes is mostly anecdotal and observational. 
Strategies suggested in both the spine and shoulder 
arthroplasty literature include dermatology referral and 
treatment for skin acne until cleared prior to surgery; ade-
quate skin preparation; tailored prophylactic antibiotics 
with effectiveness against Propionibacterium acnes; using 
a new knife for deep dissection; copious irrigation of the 
field with antibiotic containing saline; usage of titanium 
implants that may decrease biofilm formation; insertion 
of implants with new gloves; avoidance of implant con-
tact with skin edge; and avoidance of cross-links that lead 
to bursa formation.8,25,27,32,33 Our general strategy includes 
preoperative dermatological referral in the setting of back 
acne; surgical site preparation with either betadine or 
chlorhexidine; perioperative antibiotic prophylaxis; metic-
ulous hemostasis; copious irrigation with saline contain-
ing antibiotic; and routine use of postoperative drains. 
In our study, blood transfusion during the perioperative 
period trended towards a significant relationship with SSI. 
Blood transfusion is a recognized risk factor for infection 
in orthopaedic and non-orthopaedic surgery. A greater 
number of patients with infections in our study required 
two or more units of blood in the perioperative period. 
Our findings are consistent with Ho et al,11 who found that 
blood transfusion and increasing units of blood transfu-
sion were associated with infections following posterior 
spinal fusion for AIS. The increased risk of infection may be 
due to transfusion-induced immunomodulation, which 
refers to the relative immunosuppressive effects of blood 
transfusion.34 Furthermore, surgical site preparation, van-
comycin powder use and length of stay had large ORs but 
their CIs crossed 1. While previous studies have implicated 
some of these factors,11,35 larger studies are needed to bet-
ter understand the relationship between blood transfu-
sion and SSI with Propionibacterium acnes, as well as better 
elucidate the role of surgical site preparation, vancomycin 
powder use and length of stay in the pathogenesis of SSIs 
with Propionibacterium acnes.
Diagnosis of acute infection in our cohort was rela-
tively straightforward as all patients presented with active 
wound drainage within two weeks of surgery. Meanwhile, 
delayed infection can present a diagnostic challenge. Each 
of our patients with delayed infections presented with 
increasing back pain, necessitating further work-up includ-
ing labs and advanced imaging to evaluate for collection 
and fusion mass. This presentation is consistent with the 
previously described ‘honeymoon period’ of expected 
prolonged recovery and function, followed by onset of 
stiffness, pain and spasms.10,25,28 Wound drainage and/
or fever are rare presentations for delayed infections.10,36,37 
Elevation of white blood cell count and inflammatory 
markers (erythrocyte sedimentation rate and CRP) were 
seen in 50% of our patients, but this was variable and has 
been reported in less than 50% of cases.10,38 Diagnostic 
imaging modalities, such as MRI and CT, can be invaluable 
in determining the presence of a collection and assessing 
bony fusion prior to operative intervention.37,39
Established literature on treatment for Propionibacte-
rium acnes infection in idiopathic scoliosis is sparse. In a 
study on delayed postoperative infection, Richards et al8 
recommended irrigation and debridement, implant 
removal, primary wound closure and short-term postop-
erative parental antibiotic therapy (first generation cepha-
losporin) followed by oral antibiotics for one to two weeks. 
Eradication of the protective biofilm was of primary con-
cern and the authors suggested removal of hardware for 
all delayed infections.8,40 As biofilm formation appears to 
occur slowly, removal of hardware may not be required in 
acute infection.41 Meanwhile, treatment in the total shoul-
der arthroplasty literature typically consists of irrigation 
and debridement, intravenous or oral antibiotic treatment 
and suppression for four to six weeks and one- or two-
stage revision.42 Regional resistance to various antibiotics 
has been noted, leading investigators to use multidrug 
programmes often including penicillin or cephalosporin 
and rifampin.43 Vancomycin and clindamycin demonstrate 
only ‘fair’ activity.44
At our institution, routine perioperative antibiotics 
are given intravenously within one hour of skin incision, 
re-dosed after four hours for long cases, and continued 
for 24 hours after surgery. In the setting of SSI after spi-
nal deformity surgery, our treatment algorithm consists 
of surgical irrigation and debridement for all acute infec-
tions, and removal of hardware for delayed infections. At 
least four cultures are taken at the time of surgery, and 
prolonged incubation is performed for all cultures. In the 
literature, final cultures reported at 72 hours have been 
found to miss the causative organism, especially for low 
virulent skin flora like Staphylococcus epidermidis and 
Propionibacterium acnes.8,9,12 Current recommendations 
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advise culture incubation for at least ten days,8 and at our 
institution, we commonly utilize liquid media (thiogly-
colate) and incubate cultures for 14 days. Postoperative 
antibiotic coverage and duration is determined in consul-
tation with an infectious disease specialist and is based 
on culture data, sensitivities, regional microbiodata and 
relevant literature. In acute infections with Propionibac-
terium acnes, we typically treat with aminopenicillins or 
first generation cephalosporins for one to six weeks; and 
in delayed infections, we treat with intravenous cephalo-
sporins followed by oral aminopenicillins or first gener-
ation cephalosporins for a minimum of six weeks. There 
is considerable variation in the duration of antimicrobial 
therapy, and additional study is needed to determine the 
optimal duration of treatment.
Limitations of this study include its retrospective nature 
and small sample size. However, we employed a case-con-
trol study design, which is the optimal design to study rare 
events, and our study identifies several risk factors to guide 
future study. Additionally, this study was completed at a 
single institution, which raises questions about the gener-
alizability of our microbiodata on a regional and national 
level. Similarly, we did not control for other factors such as 
the number of levels fused. However, we did not find any 
significant difference in factors between groups. Further-
more, we compared our cases of Propionibacterium acnes 
infection with patients without infection, which counts as 
a drawback of this study. Additional studies comparing 
cases of infection with Propionibacterium acnes to infection 
with other pathogens may provide additional insight into 
risk factors and pathogenesis. Of note, we have had only 
one SSI in patients with idiopathic scoliosis that has been 
caused by a pathogen other than Propionibacterium acnes 
over the study period. This study derives its strengths from 
the case-control study design with 2:1 controls matched 
for age, gender and diagnosis, as well as its focus on sev-
eral risk factors that have been previously hypothesized in 
the literature. Additionally, it is to our knowledge the first 
study to describe the diagnosis and treatment of a cohort 
of patients with idiopathic scoliosis and specifically Propi-
onibacterium acnes infections.
Many advances have been made in the prevention of 
postoperative infection following surgery for idiopathic 
scoliosis. However, SSI with low-virulent organisms such as 
propionibacterium acnes continues to remain an important 
complication. In this study, we describe the presentation 
and treatment of a series of acute and delayed infections 
with propionibacterium acnes. We found no significant risk 
factors for SSI with propionibacterium acnes, likely due to 
our limited sample size. SSI with propionibacterium acnes 
can be successfully treated, however larger studies are 
needed to better describe risk factors for infection and 
establish standardized guidelines for the treatment and 
prevention of this complication.
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